Platelets are central to inflammation-related manifestations of cardiovascular diseases
(CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A 2 …

Platelet‐activating factor (PAF) is a phospholipid‐derived mediator with an established role
in multiple inflammatory states. PAF is synthesized and secreted by multiple cell types and is …

Post-infectious conditions present major health burdens but remain poorly understood. In
Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that …

The new coronavirus disease 2019 (COVID-19) pandemic is an emerging situation with high
rates of morbidity and mortality, in the pathophysiology of which inflammation and …

Recent articles report elevated markers of coagulation, endothelial injury, and
microthromboses in lungs from deceased COVID‐19 patients. However, there has been no …

Synchronized ferroptosis contributes to nephron loss in acute kidney injury (AKI). However,
the propagation signals and the underlying mechanisms of the synchronized ferroptosis for …

Atherosclerosis is a progressive vascular multifactorial process. The mechanisms
underlining the initiating event of atheromatous plaque formation are inflammation and …

Platelet-activating factor (PAF) is a lipid mediator that interacts with its receptor (PAF-R) to
carry out cell signalling. However, under certain conditions the binding of PAF to PAF-R …

Since the discovery that Greenlandic Innuits had a lower risk of developing cardiovascular
diseases (CVD) due to their diet of fish and as a consequence high polyunsaturated fatty …

Several studies have related moderate consumption of red wine with prevention of
cardiovascular diseases (CVD). According to epidemiological studies, those regions with …